7-143408737-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_005232.5(EPHA1):c.69G>T(p.Ala23=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.40 ( 11971 hom., cov: 20)
Exomes 𝑓: 0.44 ( 79115 hom. )
Consequence
EPHA1
NM_005232.5 synonymous
NM_005232.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.469
Genes affected
EPHA1 (HGNC:3385): (EPH receptor A1) This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. This gene is expressed in some human cancer cell lines and has been implicated in carcinogenesis. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BP6
Variant 7-143408737-C-A is Benign according to our data. Variant chr7-143408737-C-A is described in ClinVar as [Benign]. Clinvar id is 768216.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.469 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.427 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EPHA1 | NM_005232.5 | c.69G>T | p.Ala23= | synonymous_variant | 1/18 | ENST00000275815.4 | NP_005223.4 | |
EPHA1-AS1 | NR_033897.1 | n.74+851C>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EPHA1 | ENST00000275815.4 | c.69G>T | p.Ala23= | synonymous_variant | 1/18 | 1 | NM_005232.5 | ENSP00000275815 | P1 | |
EPHA1-AS1 | ENST00000429289.5 | n.74+851C>A | intron_variant, non_coding_transcript_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.403 AC: 57154AN: 141856Hom.: 11967 Cov.: 20
GnomAD3 genomes
AF:
AC:
57154
AN:
141856
Hom.:
Cov.:
20
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.500 AC: 1AN: 2Hom.: 0 AF XY: 0.500 AC XY: 1AN XY: 2
GnomAD3 exomes
AF:
AC:
1
AN:
2
Hom.:
AF XY:
AC XY:
1
AN XY:
2
Gnomad NFE exome
AF:
GnomAD4 exome AF: 0.439 AC: 353753AN: 806298Hom.: 79115 Cov.: 11 AF XY: 0.439 AC XY: 169745AN XY: 386494
GnomAD4 exome
AF:
AC:
353753
AN:
806298
Hom.:
Cov.:
11
AF XY:
AC XY:
169745
AN XY:
386494
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.403 AC: 57176AN: 141966Hom.: 11971 Cov.: 20 AF XY: 0.397 AC XY: 27381AN XY: 68954
GnomAD4 genome
AF:
AC:
57176
AN:
141966
Hom.:
Cov.:
20
AF XY:
AC XY:
27381
AN XY:
68954
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1132
AN:
3116
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at